ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $50,000 | -5.7% | 1,500 | 0.0% | 0.00% | +100.0% |
Q2 2022 | $53,000 | -23.2% | 1,500 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $69,000 | -30.3% | 1,500 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $99,000 | +5.3% | 1,500 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $94,000 | -24.2% | 1,500 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $124,000 | +25.3% | 1,500 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $99,000 | -13.9% | 1,500 | 0.0% | 0.00% | -25.0% |
Q4 2020 | $115,000 | +76.9% | 1,500 | 0.0% | 0.00% | +33.3% |
Q3 2020 | $65,000 | 0.0% | 1,500 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $65,000 | +51.2% | 1,500 | 0.0% | 0.00% | +50.0% |
Q1 2020 | $43,000 | – | 1,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $20,836,128 | 14.83% |
Aquilo Capital Management, LLC | 1,018,474 | $25,869,240 | 10.72% |
Rokos Capital Management LLP | 1,675,921 | $41,537,702 | 3.07% |
COMMODORE CAPITAL LP | 575,000 | $14,605,000 | 2.22% |
Privium Fund Management B.V. | 259,036 | $6,579,514 | 2.21% |
JOHNSON & JOHNSON | 247,598 | $6,288,989 | 2.05% |
WEALTH EFFECTS LLC | 156,810 | $3,982,976 | 2.04% |
M28 Capital Management LP | 67,400 | $1,711,960 | 1.94% |
Evolutionary Tree Capital Management, LLC | 51,878 | $1,317,701 | 1.83% |
Avidity Partners Management LP | 1,741,300 | $44,229,020 | 1.47% |